Sponsored links — aiSwingX™ may earn a commission at no extra cost to you. They never affect our articles, scores or rankings.
Net income went from −$5.4m in the same period a year earlier to $14.9m.
Integra Lifesciences Holdings (IART) filed its quarterly report (10-Q) for fiscal Q3 2026 on October 23. Net income went from −$5.4m in the same period a year earlier to $14.9m.
A year ago Integra Lifesciences Holdings made a loss in the same period; this time it made a profit. The question is what changed, sales or costs. The income lines show it.
34 Filing score · Small change
We find the numbers that are in the filing but not in the news, and analyze what they mean, how big they are and what to watch next quarter — with the arithmetic and quarterly metrics. Cancel any time.
On SEC EDGAR, in Integra Lifesciences Holdings' 10-Q (accession 0000917520-26-000077). The same values appear on the corresponding lines of the consolidated statements.
No. They divide two figures stated in the filing for the same period. The working is in the arithmetic table in the subscriber section.
No. Income and cash items are divided only by items covering the same length of time, and balances are always stated against the previous fiscal year-end.
Open the filing cited at the bottom of the article (e.g. the 10-Q note number) on SEC EDGAR via the link at the end of the article.
A four-item summary of the article: the key figure, what it means, the source, and what to watch next quarter. If you are short on time, read just that.
Customary quotation and sharing are fine with attribution (aiSwingX™ and the article URL). Republishing the full text elsewhere requires the License plan.